About Us
TransformaBio is a biopharmaceutical company developing innovative medicines and products through our NanoTransformer® platform. We use proprietary nanotechnology to transform difficult-to-formulate compounds, solvent-free! Our precisely engineered nanoparticles are designed to improve delivery, performance, and patient convenience.
Our programs span neurological disorders, acute care, and other areas of unmet need. We are scientific innovators, with our priority focused on a patient-centered approach. This has allowed us to create multiple differentiated products, which have been shown to meaningfully improve lives.
Our goal is simple: design treatment around when and how patients need it.
NanoTransformer®
Transforming Medicines Through Nanotechnology
Our proprietary NanoTransformer® platform transforms therapeutic compounds into nanoparticles designed to overcome formulation & delivery challenges. Our solvent-free process can improve drug performance without changing the underlying active pharmaceutical ingredient. The platform provides a versatile foundation for developing differentiated medicines across multiple routes of administration.
Nano-CNS®
Rapid Intranasal Delivery for CNS and Systemic Therapies
Nano-CNS® combines nanoparticle engineering with convenient, intranasal, dry-powder delivery which enables rapid drug absorption without needles. The platform is designed for therapies where speed, ease of administration, and reliable drug delivery can make a meaningful difference to patients. TransformaBio's programs span neurological disorders, brain injury, pain management, and other conditions requiring rapid intervention.
Nano-Derm™
Targeted Delivery to the Skin and Hair Follicles
Nano-Derm™ applies our nanoparticle technology to improve local delivery of active ingredients to the skin and hair follicles. By concentrating therapy where it is needed, the platform is designed to enhance local performance, while limiting unnecessary systemic exposure. Applications extend across pharmaceutical, dermatologic, and consumer health products.
Men’s Health
Transforming
On-Demand Treatment
We are applying our drug-delivery expertise to develop more convenient and responsive treatments for erectile dysfunction. TransformaBio's program uses intranasal nanoparticle delivery to pursue faster onset than conventional oral therapy, while maintaining a therapeutic window consistent with oral treatment.
GMP Manufacturing
From Innovation to
Scalable Production
TransformaBio brings formulation science and manufacturing expertise together, translating nanoparticle concepts into reproducible drug products. When designing drugs, we do so with four principles in mind, from the outset: Quality, Scalability, Regulatory Compliance, and eventual GMP Manufacturing. This integration helps bridge the critical gap between promising formulation technology and products ready for clinical & commercial development.
TransformaBio Pipeline
Board Members
Scientific Advisory Board
Robert Hauser, M.D., MBA
Professor, University of South Florida College of Medicine
Director, Parkinson’s Disease and Movement Disorders Center of USF
Rajesh Pahwa, M.D.
Professor, University of
Kansas Medical Center
Director, Parkinson’s Foundation Krupp Smith Family Center of Excellence
Peter LeWitt, M.D.
Professor, Wayne State University School of Medicine
Director, Parkinson’s Disease and Movement Disorders Center of Henry Ford Hospital
Stuart Isaacson, M.D.
American Academy of Neurology
Director, Parkinson’s Disease and Movement Disorders Center of Boca Raton